G&E Herbal Biotechnology Co., Ltd. (4911.TWO)
TWD 48.55
(-1.42%)
TWD 48.55
(-1.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 883.09 Million TWD | 12.82% |
| 2022 | 782.77 Million TWD | 13.1% |
| 2021 | 692.13 Million TWD | -2.75% |
| 2020 | 711.72 Million TWD | -2.48% |
| 2019 | 729.85 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 874.86 Million TWD | -0.61% |
| 2024 Q1 | 880.25 Million TWD | -0.32% |
| 2023 Q1 | 773.43 Million TWD | 0.0% |
| 2023 FY | 883.09 Million TWD | 12.82% |
| 2023 Q4 | 883.09 Million TWD | 12.88% |
| 2023 Q3 | 782.3 Million TWD | 1.3% |
| 2023 Q2 | 772.25 Million TWD | -0.15% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 69.558% |
| Level Biotechnology Inc. | 822.67 Million TWD | -7.345% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -32.852% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -60.929% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 77.321% |
| GlycoNex Incorporation | 1.55 Billion TWD | 43.129% |
| VBI | 452.1 Million TWD | -95.331% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 24.916% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -17.971% |
| Visgeneer Inc. | 397.17 Million TWD | -122.343% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 76.578% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 59.098% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 85.506% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -1100.542% |
| Enimmune corporation | 604.82 Million TWD | -46.008% |
| TaiRx, Inc. | 833.74 Million TWD | -5.919% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 71.384% |
| EirGenix Inc. | 11.16 Billion TWD | 92.089% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -54.08% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 48.428% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 75.447% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 15.934% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -193.356% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -233.675% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -100.162% |
| RBC Bioscience Corporation | 753.79 Million TWD | -17.154% |
| BiOptic Inc. | 613.77 Million TWD | -43.88% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 50.351% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 23.852% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -36.946% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 71.57% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -589.665% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -133.399% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 22.115% |
| Neith Corporation | 192.15 Million TWD | -359.579% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -496.952% |
| NaviFUS Corp. | 490.53 Million TWD | -80.027% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 27.953% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 35.227% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -66.891% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 23.962% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 46.682% |
| AP Biosciences Inc | 890.75 Million TWD | 0.86% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 89.644% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -172.436% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 33.783% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 67.426% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 94.252% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -115.254% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -122.526% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 57.46% |
| TCI GENE Inc. | 1.16 Billion TWD | 24.259% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -199.78% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 35.225% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 6.229% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -26.436% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 77.665% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 76.898% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 28.194% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 84.241% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 16.847% |
| Acepodia, Inc. | 6.81 Billion TWD | 87.049% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 76.922% |